Certified by Founder
Lodge
CatalYm GmbH
start up
Germany
- Martinsried, Bayern
- 16/07/2024
- Series D
- $150,000,000
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
- Industry Biotechnology Research
- Website https://www.catalym.com/
- LinkedIn https://www.linkedin.com/company/catalym/
Related People
Phil L'HuillierFounder
United Kingdom -
Greater London, England
Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors
Syntracts | $5,300,000 | (Oct 24, 2025)
GradBridge | $20,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
CipherOwl | $15,000,000 | (Oct 24, 2025)
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
Vermeer | $10,000,000 | (Oct 24, 2025)
GammaTime | $14,000,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Apriority Financial, Inc. | $2,300,000 | (Oct 24, 2025)
OneAM | $4,700,000 | (Oct 24, 2025)
🌱 Rightcharge | $2,131,920 | (Oct 24, 2025)
Tensormesh | $4,500,000 | (Oct 24, 2025)